Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus
出版年份 2017 全文链接
标题
Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus
作者
关键词
-
出版物
EPILEPSIA
Volume 58, Issue 7, Pages 1199-1207
出版商
Wiley
发表日期
2017-06-09
DOI
10.1111/epi.13787
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy
- (2016) Pavel Klein et al. EPILEPSIA
- Time to onset of sustained ≥50% responder status in patients with focal (partial-onset) seizures in three phase III studies of adjunctive brivaracetam treatment
- (2016) Pavel Klein et al. EPILEPSIA
- Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein
- (2016) Martyn D. Wood et al. EPILEPSIA
- Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment
- (2016) Henrik Klitgaard et al. EPILEPSIA
- Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society
- (2016) Tracy Glauser et al. Epilepsy Currents
- Status Epilepticus: Epidemiology and Public Health Needs
- (2016) Sebastián Sánchez et al. Journal of Clinical Medicine
- Pharmacotherapy for Status Epilepticus
- (2015) Eugen Trinka et al. DRUGS
- A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures
- (2015) Pavel Klein et al. EPILEPSIA
- Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action
- (2015) Jean-Marie Nicolas et al. EPILEPSIA
- Brivaracetam Single and Multiple Rising Oral Dose Study in Healthy Japanese Participants: Influence of CYP2C19 Genotype
- (2014) Armel Stockis et al. Drug Metabolism and Pharmacokinetics
- Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial
- (2013) Victor Biton et al. EPILEPSIA
- Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double-blind, randomized, placebo-controlled trial
- (2013) Philippe Ryvlin et al. EPILEPSIA
- Guidelines for the Evaluation and Management of Status Epilepticus
- (2012) Gretchen M. Brophy et al. Neurocritical Care
- Intramuscular versus Intravenous Therapy for Prehospital Status Epilepticus
- (2012) Robert Silbergleit et al. NEW ENGLAND JOURNAL OF MEDICINE
- The acute and chronic effects of the novel anticonvulsant lacosamide in an experimental model of status epilepticus
- (2011) Claude G. Wasterlain et al. EPILEPSY RESEARCH
- Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties
- (2011) Michel Gillard et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A
- (2008) A Matagne et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started